Status:
RECRUITING
Pain ASsessment in CAncer Patients by Machine LEarning (PASCALE)
Lead Sponsor:
National Cancer Institute, Naples
Collaborating Sponsors:
Federico II University
Conditions:
Oncology
Cancer Pain
Eligibility:
All Genders
18+ years
Brief Summary
In cancer patients, the integration between anticancer therapies and palliative care is of fundamental importance. In this context, telemedicine can improve the quality of life (QoL) of chronic patien...
Detailed Description
For the entire duration of the study, patients will remain under the care of the Early Palliative Care and Simultaneous Care Outpatient team of the Istituto Nazionale Tumori, Fondazione Pascale, at ho...
Eligibility Criteria
Inclusion
- Patients aged \> 18 years
- Home care patients diagnosed with advanced cancer disease and life expectancy ≤ 1 year
- Patients receiving treatment for cancer pain
- Patients who have given their consent
Exclusion
- Patients aged \< 18 years
- Willingness to sign the informed consent form (unable to read or write)
- Cognitive deficit (e.g. Alzheimer disease or senile dementia)
Key Trial Info
Start Date :
June 21 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 1 2025
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT04726228
Start Date
June 21 2021
End Date
October 1 2025
Last Update
July 29 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
National Cancer Institute of Naples
Naples, Campania, Italy, 80131
2
A.O.U. Federico II
Napoli, Campania, Italy